Featured Research

from universities, journals, and other organizations

Crab, other crustacean shells, may hold key to preventing, treating inflammatory bowel disease

Date:
June 24, 2014
Source:
Florida Atlantic University
Summary:
Microparticles in crab, shrimp and lobster shells have anti-inflammatory mechanisms that that could lead to the development of novel preventive and therapeutic strategies for those who suffer from inflammatory bowel disease. Since these shells are abundant and a major waste in the seafood industry, they may provide an alternative to costly drugs that don't always work.

Researchers at FAU and their colleagues have developed an oral form of microparticles in crab and other crustacean shells as a dietary supplement that may prevent and treat IBD and other inflammatory diseases.
Credit: Image courtesy of Florida Atlantic University

Yoshimi Shibata, Ph.D., professor of biomedical science in the Charles E. Schmidt College of Medicine at Florida Atlantic University, has received a $380,552 grant from the National Institute of Complementary and Alternative Medicine of the National Institutes of Health (NIH) to further investigate how microparticles called "chitin" found in crab, shrimp and lobster shells have anti-inflammatory mechanisms that could lead to the development of novel preventive and therapeutic strategies for individuals who suffer from inflammatory bowel disease (IBD) and others diseases.

Current medications for IBD include antibiotics, corticosteroids and other biologic anti-inflammatory drugs that are costly and don't always work. Since lobster, crab and shrimp shells are a major waste in the seafood industry, chitin is abundant and low-cost to prepare. Chitin microparticles are also non-toxic, biodegradable and non-allergenic, and therefore safe for oral ingestion as a dietary food supplement.

Shibata's collaborators are Zhongwei Li, Ph.D. in FAU's Charles E. Schmidt College of Medicine; C. Kathleen Dorey, Ph.D. at Virginia Tech Carilion School of Medicine; and Emiko Mizoguchi, M.D., Ph.D., with the Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School. Shibata is an immunologist whose research focuses on macrophages, which are multifunctional cells that are essential for the host protective immune systems and inflammation.

Many scientists now believe that most -- or perhaps all -- chronic diseases stem from chronic inflammation, which plays a direct role in diseases such as IBD, diabetes, cardiovascular disease, cancer, asthma and many other diseases.

"Under normal conditions, inflammation is a process that actually protects health and promotes healing by mobilizing the immune system to attack invading bacteria and kill them through the immune system reaction," said Shibata. "Chronic inflammation on the other hand harms instead of heals because the immune system attack never stops."

Crab, shrimp and lobster shells contain carbohydrates, calcium and protein. Shibata and his colleagues designed the active carbohydrates in these crustaceans by removing the calcium and protein and making small particles with the carbohydrates that are similar to bacteria, called mimetic microbes. They have developed an oral form of this substance as a dietary supplement. The team has demonstrated that oral administration of chitin microparticles reduces disease conditions of allergic asthma, food allergies, colitis and food borne infections in animal models and seasonal allergies in humans. They have also conducted additional studies to advance their understanding of the mechanisms underlying the effects of chitin microparticles on macrophage activation.

"In this new study, we are going to focus on intestinal macrophages and how these mimetic microbes we have developed can produce anti-inflammatory activities, normalize the gut bacterial flora and ultimately improve the symptoms associated with inflammatory bowel disease," said Shibata.

According to the Crohn's & Colitis Foundation of America, more than 1.4 million Americans suffer from Crohn's disease and ulcerative colitis, and approximately 70,000 new cases of IBD are diagnosed each year. Children under the age of 18 are the fastest growing population of IBD patients.

"The causes of inflammatory bowel disease and the factors that influence its activity are not known," said David J. Bjorkman, M.D., M.S.P.H., a gastroenterologist and dean and executive director of medical affairs for FAU's Charles E. Schmidt College of Medicine. "The impact of this condition can range from mild to severe debilitation."

"The important research that Dr. Shibata and his colleagues are conducting will also engage our graduate and undergraduate students in clinically-relevant immunology research, encourage their scientific development, and give them a deeper appreciation of complementary and alternative medicines," said John W. Newcomer, M.D., executive vice dean of FAU's Charles E. Schmidt College of Medicine and interim vice president for research at FAU.


Story Source:

The above story is based on materials provided by Florida Atlantic University. Note: Materials may be edited for content and length.


Cite This Page:

Florida Atlantic University. "Crab, other crustacean shells, may hold key to preventing, treating inflammatory bowel disease." ScienceDaily. ScienceDaily, 24 June 2014. <www.sciencedaily.com/releases/2014/06/140624105235.htm>.
Florida Atlantic University. (2014, June 24). Crab, other crustacean shells, may hold key to preventing, treating inflammatory bowel disease. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2014/06/140624105235.htm
Florida Atlantic University. "Crab, other crustacean shells, may hold key to preventing, treating inflammatory bowel disease." ScienceDaily. www.sciencedaily.com/releases/2014/06/140624105235.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO Calls for Ban on E-Cigarette Sales to Minors

WHO Calls for Ban on E-Cigarette Sales to Minors

AFP (Aug. 26, 2014) The World Health Organization called Tuesday on governments should ban the sale of e-cigarettes to minors, warning that they pose a "serious threat" to foetuses and young people. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Official: British Ebola Sufferer Receiving Experimental Drug

Official: British Ebola Sufferer Receiving Experimental Drug

AFP (Aug. 26, 2014) A British nurse infected with Ebola while working in Sierra Leone is being given the same experimental drug used on two US missionaries who have recovered for the disease, doctors in London say. Duration: 00:44 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins